Today, many health plans prioritize improving their provider network performance and meeting government healthcare program
requirements. However, with rising specialty drug costs, health plans recognize the important role outcomes-based contracting with
life sciences manufacturers will play over the next five years.
In this opinion brief, Truven Health shares the US payer perspective on outcomes-based contracts — what it will take to make these innovative contracts meaningful, sustainable and scalable. The brief provides insights from conversations with chief medical officers and formulary managers of health plans, pharmacy benefits managers and accountable care organizations (ACOs)
News from our partners.